RH's long-term vision of $20 billion in sales and 20% margins remains distant. Read why I see no reason to buy the dip of RH ...

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

LendingClub’s stock fell due to market uncertainty. Read why LC stock might be undervalued compared to peers, but risks ...

Tecogen's innovative gas-powered chiller disrupts data center cooling, backed by a Vertiv partnership. See why I rate TGEN ...

Tesla's competitive advantage has eroded, with stagnant deliveries, flat revenues, and declining operating margins. See why I ...

Nvidia's Blackwell chips are set to boost earnings. Read why NVDA stock is an attractive investment opportunity amid ...

St. Joe Company’s Bay-Walton Sector Plan covers 110,500 acres, aiming to develop 170,200 residential units. Read why JOE ...

Stay updated with a weekly recap covering market movements, economic insights, top news, and geopolitical events shaping the ...

MercadoLibre reiterated its strong growth, with net income growing 287% year-over-year. See why I rate MELI stock a strong ...

The architects of the new US foreign economic policy expected dollar appreciation to absorb some of the cost of US tariffs ...

Prysmian (PRYMF) is more immune to a tariff war thanks to an exposure to both the US and European markets. See why I continue ...

MDVWX allocates more assets to profitable, undervalued stocks compared to benchmarks IWD and SPY. Read what makes MDVWX fund ...